Clinical trial reportInvestigational new drugsPublished
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Lewis Katz School of Medicine, Thomas Jefferson University, with Temple Health, Temple University linked by the institution reference. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- Investigational new drugs
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Sulfonamides; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Sorafenib; Hepatocellular carcinoma; Bcl2; Navitoclax; Abt-263
- PubMed ID
- 38270822
- Added to directory
- Source checked